Mark Walport

Professor Mark Walport
Born	Mark Jeremy Walport (1953-01-25) 25 January 1953[1] London
Residence	United Kingdom
Citizenship	United Kingdom
Fields	Immunology, Rheumatology
Institutions	Hammersmith Hospital Royal Brompton Hospital Guy's Hospital Imperial College School of Medicine Wellcome Trust University of Cambridge Government of the United Kingdom
Alma mater	Clare College, Cambridge[1]
Thesis	The biology of complement receptors (1986)
Doctoral advisor	Peter Lachmann[2]
Known for	Director of Wellcome Trust (2003-2013)[3] Government Chief Scientific Adviser (2013-date)[4]
Notable awards	Roche Rheumatology Prize (1991) Graham Bull Prize in Clinical Science (1996) Fellow of the Academy of Medical Sciences (1998) Knight Bachelor (2009) Fellow of the Royal Society (2011)[5]
Spouse	Julia Elizabeth Neild[1]
Website
twitter.com/uksciencechief royalsociety.org/people/mark-walport

Education

Walport is the son of a general practitioner and was born in London. He was educated at St Paul's School, London,^[1] studied medicine at the University of Cambridge (Clare College) and completed his clinical training at Hammersmith, Guy's and Brompton Hospitals in London.^[6][11] He was awarded a PhD for research into complement receptors under the supervision of Peter Lachmann in 1986 at the University of Cambridge.^[12]

Career

Previously Walport was Director of the Wellcome Trust from 2003 to 2013.^[3] Before this, he was Professor of Medicine (from 1991) and Head of the Division of Medicine (from 1997) at Imperial College London,^[6] where he led a research team that focused on the immunology and genetics of rheumatic diseases.^{[13][14][15][16][17][18][19][20]}

Honours

Walport was knighted in the 2009 New Year Honours list for services to medical research. He was elected a Fellow of the Royal Society in 2011.^[5][6]

References

1. ↑ 1.0 1.1 1.2 1.3 1.4 "WALPORT, Sir Mark (Jeremy)" (Who's Who 2013, A & C Black, an imprint of Bloomsbury Publishing plc, 2013; online edn, Oxford University Press). (subscription required)
2. ↑ Reed, Tanya (11 July 2003). "Wellcome to a new beginning". Reporter: The newspaper of Imperial College London (131). 
3. ↑ 3.0 3.1 Vogel, G. (2003). "United Kingdom: Mark Walport to Take Reins at Wellcome Trust". Science 299 (5608): 803a–. doi:10.1126/science.299.5608.803a. PMID 12574591. 
4. ↑ 4.0 4.1 Callaway, E. (2012). "Britain names next chief science adviser: Immunologist Mark Walport, head of one of the world’s largest biomedical charities, will take on role in 2013.". Nature 487 (7405): 20. doi:10.1038/487020a. 
5. ↑ 5.0 5.1 "Sir Mark Walport FRS | Royal Society". Retrieved 2012-07-05. 
6. ↑ 6.0 6.1 6.2 6.3 "Dr Sir Mark Walport". Debrett's People of Today. Retrieved 14 February 2012. 
7. ↑ Mayor, S. (2012). "Mark Walport will be next UK government chief scientific adviser, cabinet office announces". BMJ 345: e4621. doi:10.1136/bmj.e4621. PMID 22767620. 
8. ↑ Kain, K. H. (2010). "Funding scientific discovery: An interview with Sir Mark Walport". Disease Models & Mechanisms 3 (5–6): 265–267. doi:10.1242/dmm.005710. PMID 20427555. 
9. ↑ Anon (2012). "Good advice: The UK government's latest appointment offers hope for British science.". Nature 487 (7405): 5. doi:10.1038/487005b. 
10. ↑ Gibney, Elizabeth (29 June 2012). "New chief scientific adviser announced". Times Higher Education. 
11. ↑ Morris, K. (2003). "Mark Walport". The Lancet 362 (9382): 498–499. doi:10.1016/S0140-6736(03)14090-1. 
12. ↑ Walport, Mark Jeremy (1986). The biology of complement receptors (PhD thesis). University of Cambridge. 
13. ↑ "Mark Walport, Ph.D.,MB. BChir. , Member, Scientific Board". Grand Challenges in Global Health. Retrieved 14 February 2012. 
14. ↑ Walport, M.; Foulkes, I.; Weissberg, P.; Morgan, D.; Nebhrajani, S. (2012). "Medical research: No catch to UK charity funding". Nature 482 (7385): 308. doi:10.1038/482308a. PMID 22337042. 
15. ↑ Collins, P. Y.; Patel, V.; Joestl, S. S.; March, D.; Insel, T. R.; Daar, A. S.; Scientific Advisory Board the Executive Committee of the Grand Challenges on Global Mental Health; Bordin, I. A.; Anderson, E. J.; Dhansay, M.; Phillips, C.; Shurin, R. I.; Walport, W.; Ewart, Y.; Savill, S. E.; Bordin, K.; Costello, S.; Durkin, S.; Fairburn, A.; Glass, A.; Hall, A.; Huang, M. M.; Hyman, V.; Jamison, B. J.; Kaaya, S.; Kapur, P. A.; Kleinman, D. J.; Ogunniyi, W.; Otero-Ojeda, M. A.; Poo, W.; Ravindranath, A. (2011). "Grand challenges in global mental health". Nature 475 (7354): 27–30. doi:10.1038/475027a. PMC 3173804. PMID 21734685. 
16. ↑ Yamada, T.; Dautry, A.; Walport, M. (2008). "Ready for avian flu?". Nature 454 (7201): 162. doi:10.1038/454162a. PMID 18615064. 
17. ↑ Pickering, M. C.; Warren, J.; Rose, K. L.; Carlucci, F.; Wang, Y.; Walport, M. J.; Cook, H. T.; Botto, M. (2006). "Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice". Proceedings of the National Academy of Sciences 103 (25): 9649–9654. doi:10.1073/pnas.0601094103. PMC 1476693. PMID 16769899. 
18. ↑ Brown, J. S.; Hussell, T.; Gilliland, S. M.; Holden, D. W.; Paton, J. C.; Ehrenstein, M. R.; Walport, M. J.; Botto, M. (2002). "The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice". Proceedings of the National Academy of Sciences 99 (26): 16969–16974. doi:10.1073/pnas.012669199. PMC 139253. PMID 12477926. 
19. ↑ Botto, M.; Fong, K. Y.; So, A. K.; Barlow, R.; Routier, R.; Morley, B. J.; Walport, M. J. (1992). "Homozygous hereditary C3 deficiency due to a partial gene deletion". Proceedings of the National Academy of Sciences of the United States of America 89 (11): 4957–4961. doi:10.1073/pnas.89.11.4957. PMC 49207. PMID 1350678. 
20. ↑ Taylor, P. R.; Carugati, A.; Fadok, V. A.; Cook, H. T.; Andrews, M.; Carroll, M. C.; Savill, J. S.; Henson, P. M.; Botto, M.; Walport, M. J. (2000). "A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo". Journal of Experimental Medicine 192 (3): 359–366. doi:10.1084/jem.192.3.359. PMC 2193213. PMID 10934224.